BTW
LLY icon

Boston Trust Walden’s Eli Lilly LLY Stock Holding History

Boston Trust Walden’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.95M Buy
3,295
+114
+4% +$116K 0.03% 235
2026
Q1 		$2.93M Sell
3,181
-20
-0.6% -$20.3K 0.02% 250
2025
Q4 		$3.44M Sell
3,201
-42
-1% -$40.2K 0.03% 237
2025
Q3 		$2.47M Sell
3,243
-31
-0.9% -$23.1K 0.02% 242
2025
Q2 		$2.55M Sell
3,274
-10
-0.3% -$7.77K 0.02% 241
2025
Q1 		$2.71M Buy
3,284
+40
+1% +$33.3K 0.02% 239
2024
Q4 		$2.5M Sell
3,244
-60
-2% -$49.7K 0.02% 242
2024
Q3 		$2.93M Sell
3,304
-29
-0.9% -$26.1K 0.02% 240
2024
Q2 		$3.02M Sell
3,333
-108
-3% -$86.4K 0.02% 235
2024
Q1 		$2.68M Sell
3,441
-185
-5% -$132K 0.02% 237
2023
Q4 		$2.11M Buy
3,626
+130
+4% +$75.9K 0.02% 243
2023
Q3 		$1.88M Sell
3,496
-150
-4% -$77.3K 0.02% 248
2023
Q2 		$1.71M Buy
3,646
+402
+12% +$169K 0.01% 253
2023
Q1 		$1.11M Sell
3,244
-90
-3% -$30.4K 0.01% 272
2022
Q4 		$1.22M Hold
3,334
– – 0.01% 270
2022
Q3 		$1.08M Hold
3,334
– – 0.01% 268
2022
Q2 		$1.08M Buy
3,334
+1,046
+46% +$314K 0.01% 269
2022
Q1 		$655K Sell
2,288
-2,030
-47% -$522K 0.01% 301
2021
Q4 		$1.19M Hold
4,318
– – 0.01% 277
2021
Q3 		$998K Hold
4,318
– – 0.01% 282
2021
Q2 		$991K Hold
4,318
– – 0.01% 285
2021
Q1 		$807K Sell
4,318
-100
-2% -$19.6K 0.01% 293
2020
Q4 		$746K Buy
4,418
+108
+3% +$16.1K 0.01% 294
2020
Q3 		$638K Sell
4,310
-99
-2% -$15.3K 0.01% 301
2020
Q2 		$724K Sell
4,409
-750
-15% -$115K 0.01% 295
2020
Q1 		$716K Sell
5,159
-90
-2% -$12.4K 0.01% 287
2019
Q4 		$690K Sell
5,249
-161
-3% -$18.7K 0.01% 308
2019
Q3 		$605K Sell
5,410
-200
-4% -$22.3K 0.01% 315
2019
Q2 		$622K Buy
5,610
+30
+0.5% +$3.53K 0.01% 320
2019
Q1 		$724K Sell
5,580
-50
-0.9% -$6.08K 0.01% 315
2018
Q4 		$652K Hold
5,630
– – 0.01% 311
2018
Q3 		$604K Hold
5,630
– – 0.01% 324
2018
Q2 		$480K Sell
5,630
-1,647
-23% -$135K 0.01% 333
2018
Q1 		$563K Sell
7,277
-400
-5% -$32.2K 0.01% 326
2017
Q4 		$648K Sell
7,677
-260
-3% -$22.1K 0.01% 322
2017
Q3 		$679K Sell
7,937
-448
-5% -$36.7K 0.01% 325
2017
Q2 		$690K Buy
8,385
+603
+8% +$49.2K 0.01% 316
2017
Q1 		$655K Buy
7,782
+647
+9% +$51.8K 0.01% 307
2016
Q4 		$525K Hold
7,135
– – 0.01% 310
2016
Q3 		$573K Hold
7,135
– – 0.01% 309
2016
Q2 		$562K Sell
7,135
-75
-1% -$5.65K 0.01% 310
2016
Q1 		$519K Buy
7,210
+1,000
+16% +$75.7K 0.01% 312
2015
Q4 		$523K Hold
6,210
– – 0.01% 309
2015
Q3 		$520K Buy
6,210
+3,760
+153% +$317K 0.01% 318
2015
Q2 		$205K Buy
+2,450
New +$187K ﹤0.01% 346

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Boston Trust Walden's LLY Position: Q2 2026 in Review

Boston Trust Walden increased its Eli Lilly (LLY) stake by 3.6% in Q2 2026, buying an estimated $116K and bringing the position to 3,295 shares worth $3.95M. The position accounts for 0.03% of the portfolio, ranked #235.

Boston Trust Walden first reported a position in LLY in Q2 2015 and has held it in 45 quarters since. 1,724 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Boston Trust Walden held 3,295 shares of Eli Lilly worth $3.95M as of Q2 2026.
  • Boston Trust Walden bought 114 Eli Lilly shares in Q2 2026, an estimated $116K.
  • Eli Lilly made up 0.03% of Boston Trust Walden's portfolio in Q2 2026, its #235 holding.
  • Boston Trust Walden first reported a position in Eli Lilly in Q2 2015 and has held it in 45 quarters since.
  • 1,724 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.